NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-17 00:00 |
투자판단관련주요경영사항 (회생절차 개시신청 결정의 건)
|
Korean | 5.6 KB | ||
| 2024-04-11 00:00 |
[기재정정]사업보고서 (2023.12)
|
Korean | 1.9 MB | ||
| 2024-04-08 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.9 KB | ||
| 2024-04-05 00:00 |
감사보고서제출
|
Korean | 25.2 KB | ||
| 2024-04-05 00:00 |
사업보고서 (2023.12)
|
Korean | 449.6 KB | ||
| 2024-04-05 00:00 |
기타시장안내 (상장폐지 관련)
|
Korean | 3.0 KB | ||
| 2024-04-05 00:00 |
주권매매거래정지기간변경 (상장폐지 사유 발생)
|
Korean | 5.1 KB | ||
| 2024-04-05 00:00 |
기타시장안내 (상장적격성 실질심사 관련 절차 안내)
|
Korean | 3.3 KB | ||
| 2024-03-29 00:00 |
정기주주총회결과
|
Korean | 29.6 KB | ||
| 2024-03-25 00:00 |
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
|
Korean | 4.6 KB | ||
| 2024-03-25 00:00 |
불성실공시법인지정 (공시번복 1건, 공시불이행 4건)
|
Korean | 9.2 KB | ||
| 2024-03-25 00:00 |
기타시장안내 (상장적격성 실질심사 관련 안내)
|
Korean | 2.9 KB | ||
| 2024-03-25 00:00 |
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
|
Korean | 3.0 KB | ||
| 2024-03-21 00:00 |
기타경영사항(자율공시) (감사보고서 지연 제출)
|
Korean | 6.6 KB | ||
| 2024-03-21 00:00 |
사업보고서제출기한연장신고서 (2023.12)
|
Korean | 7.6 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
